By Dean Seal
Shares of Teladoc Health slumped after the company logged a wider fourth-quarter loss than analysts had expected and provided tepid guidance for 2025.
The stock was down 18% at $9 in early trading. Shares are now teetering into negative territory year-to-date. They were trading at $15.16 this time a year ago.
The virtual care company reported a loss of 28 cents a share for the fourth quarter. Analysts polled by FactSet had been expecting a smaller 26-cent per-share loss. Revenue of $640.5 million for the quarter was $1 million higher than projected.
Teladoc guided for $2.47 billion to $2.58 billion in revenue in 2025, along with a net loss of 50 cents to $1.10 a share. The midpoint of those ranges were weaker than analyst projections, which have since been adjusted to reflect lower sales and a wider loss, according to FactSet.
The current year is a known transition year for Teladoc, and the stock decline likely reflects that guidance is heavily weighted toward the back-end of the year, Stifel analysts said in a research note.
"We expect TDOC's stock price to remain volatile given the absence of near-term catalysts and a meaningful short interest," the analysts said.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
February 27, 2025 10:00 ET (15:00 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。